BRITTNEY PARSONS: Open Payments
NPI 1306442363 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$950 in 52 payments from 11 companies in 2025. Trend: 2023 $421 · 2024 $1,205 · 2025 $950
Food & beverage: $950
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 16 | $230 |
| Alkermes, Inc. | 10 | $189 |
| E.R. Squibb & Sons, L.L.C. | 6 | $164 |
| Janssen Pharmaceuticals, Inc | 4 | $79 |
| Neurocrine BioSciences, Inc. | 3 | $57 |
| Teva Pharmaceuticals USA, Inc. | 3 | $52 |
| Vanda Pharmaceuticals Inc. | 3 | $50 |
| ABBVIE INC. | 3 | $46 |
| Lundbeck LLC | 2 | $32 |
| Axsome Therapeutics, Inc. | 1 | $31 |
Products named: ARISTADA, COBENFY, ABILIFY ASIMTUFII, REXULTI, INVEGA SUSTENNA, INGREZZA, HETLIOZ, VRAYLAR.
Industry payments across NC — which companies pay providers there.
